ProCE Banner Activity

Current and Emerging Biomarkers in Lung Cancer Therapy

Slideset Download
Download these slides to review expert insights from a medical oncologist on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.

Released: October 13, 2020

Expiration: October 12, 2021

No longer available for credit.

Share

Faculty

Joel W. Neal

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California